These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10362320)

  • 41. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat.
    Liu XH; Eun BL; Silverstein FS; Barks JD
    Pediatr Res; 1996 Dec; 40(6):797-803. PubMed ID: 8947953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mannitol therapy in perinatal hypoxic-ischemic brain damage in rats.
    Mujsce DJ; Towfighi J; Stern D; Vannucci RC
    Stroke; 1990 Aug; 21(8):1210-4. PubMed ID: 2117785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.
    Komar G; Seppänen M; Eskola O; Lindholm P; Grönroos TJ; Forsback S; Sipilä H; Evans SM; Solin O; Minn H
    J Nucl Med; 2008 Dec; 49(12):1944-51. PubMed ID: 18997048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dexamethasone effects on cerebral protein synthesis prior to and following hypoxia-ischemia in immature rat.
    Tuor UI; Manley JJ; Fyfe C; Bascaramurty S
    Brain Res Bull; 1999 Jan; 48(1):61-4. PubMed ID: 10210168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding.
    Evans SM; Judy KD; Dunphy I; Jenkins WT; Nelson PT; Collins R; Wileyto EP; Jenkins K; Hahn SM; Stevens CW; Judkins AR; Phillips P; Geoerger B; Koch CJ
    Cancer Res; 2004 Mar; 64(5):1886-92. PubMed ID: 14996753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status.
    Evans SM; Jenkins WT; Shapiro M; Koch CJ
    Adv Exp Med Biol; 1997; 411():215-25. PubMed ID: 9269430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo measurement of the hypoxia marker EF5 in Shionogi tumours using (19)F magnetic resonance spectroscopy.
    Hoff MN; Yapp DT; Yung AC; Oliver TS; Kozlowski P
    Int J Radiat Biol; 2008 Mar; 84(3):237-42. PubMed ID: 18300024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of hypoxia in human squamous cell carcinoma by EF5 binding.
    Evans SM; Hahn S; Pook DR; Jenkins WT; Chalian AA; Zhang P; Stevens C; Weber R; Weinstein G; Benjamin I; Mirza N; Morgan M; Rubin S; McKenna WG; Lord EM; Koch CJ
    Cancer Res; 2000 Apr; 60(7):2018-24. PubMed ID: 10766193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles.
    Koch CJ; Evans SM
    Adv Exp Med Biol; 2003; 510():285-92. PubMed ID: 12580442
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5.
    Koch CJ
    Methods Enzymol; 2002; 352():3-31. PubMed ID: 12125356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypoxia, hyperoxia, ischemia, and brain necrosis.
    Miyamoto O; Auer RN
    Neurology; 2000 Jan; 54(2):362-71. PubMed ID: 10668697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of ketamine on hypoxic-ischemic brain damage in newborn rats.
    Spandou E; Karkavelas G; Soubasi V; Avgovstides-Savvopoulou P; Loizidis T; Guiba-Tziampiri O
    Brain Res; 1999 Feb; 819(1-2):1-7. PubMed ID: 10082854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypoxia is important in the biology and aggression of human glial brain tumors.
    Evans SM; Judy KD; Dunphy I; Jenkins WT; Hwang WT; Nelson PT; Lustig RA; Jenkins K; Magarelli DP; Hahn SM; Collins RA; Grady MS; Koch CJ
    Clin Cancer Res; 2004 Dec; 10(24):8177-84. PubMed ID: 15623592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation.
    Evans SM; Hahn SM; Magarelli DP; Koch CJ
    Am J Clin Oncol; 2001 Oct; 24(5):467-72. PubMed ID: 11586098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bcl-2, Bax and Bcl-x expression following hypoxia-ischemia in the infant rat brain.
    Ferrer I; Pozas E; López E; Ballabriga J
    Acta Neuropathol; 1997 Dec; 94(6):583-9. PubMed ID: 9444360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypoxia-ischemia produces focal disruption of glutamate receptors in developing brain.
    Silverstein FS; Torke L; Barks J; Johnston MV
    Brain Res; 1987 Jul; 431(1):33-9. PubMed ID: 2887258
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Qian Y; Von Eyben R; Liu Y; Chin FT; Miao Z; Apte S; Carter JN; Binkley MS; Pollom EL; Harris JP; Prionas ND; Kissel M; Simmons A; Diehn M; Shultz DB; Brown JM; Maxim PG; Koong AC; Graves EE; Loo BW
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1183-1192. PubMed ID: 29859786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat.
    Gidday JM; Fitzgibbons JC; Shah AR; Park TS
    Neurosci Lett; 1994 Feb; 168(1-2):221-4. PubMed ID: 8028780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transient global brain hypoxia-ischemia in adult rats: neuronal damage, glial proliferation, and alterations in inositol phospholipid hydrolysis.
    Fortuna S; Pestalozza S; Lorenzini P; Bisso GM; Morelli L; Michalek H
    Neurochem Int; 1997 Oct; 31(4):563-9. PubMed ID: 9308006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat.
    Globus MY; Busto R; Martinez E; Valdés I; Dietrich WD; Ginsberg MD
    J Neurochem; 1991 Aug; 57(2):470-8. PubMed ID: 2072098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.